DE69738667D1 - Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure - Google Patents
Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäureInfo
- Publication number
- DE69738667D1 DE69738667D1 DE69738667T DE69738667T DE69738667D1 DE 69738667 D1 DE69738667 D1 DE 69738667D1 DE 69738667 T DE69738667 T DE 69738667T DE 69738667 T DE69738667 T DE 69738667T DE 69738667 D1 DE69738667 D1 DE 69738667D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- colonmicroadenoma
- colonadomeno
- preventation
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1820296P | 1996-05-23 | 1996-05-23 | |
PCT/EP1997/002632 WO1997044043A1 (en) | 1996-05-23 | 1997-05-22 | Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69738667D1 true DE69738667D1 (de) | 2008-06-19 |
Family
ID=21786767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69738667T Expired - Lifetime DE69738667D1 (de) | 1996-05-23 | 1997-05-22 | Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure |
Country Status (10)
Country | Link |
---|---|
US (1) | US6426340B1 (de) |
EP (1) | EP0906106B1 (de) |
JP (2) | JP2000510858A (de) |
AT (1) | ATE394107T1 (de) |
AU (1) | AU3091597A (de) |
CA (1) | CA2253593C (de) |
DE (1) | DE69738667D1 (de) |
ES (1) | ES2306459T3 (de) |
PT (1) | PT906106E (de) |
WO (1) | WO1997044043A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1113785B1 (de) * | 1998-07-24 | 2005-04-13 | Seo Hong Yoo | Klare wässrige lösungen enthaltend gallensäuren |
JP2002522381A (ja) * | 1998-08-06 | 2002-07-23 | ストレンメル,ボルフガング | 粘膜保護用医薬としてのホスファチジルコリン |
ATE450865T1 (de) * | 1999-09-28 | 2009-12-15 | Panacea Biotec Ltd | Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid |
US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
CA2503811A1 (en) * | 2002-11-01 | 2004-05-21 | James Kaput | Identification of diet-regulated disease-associated genes |
WO2008088836A2 (en) * | 2007-01-16 | 2008-07-24 | The Burnham Institute For Medical Research | Compositions and methods for treatment of colorectal cancer |
EP2255813A1 (de) * | 2009-05-29 | 2010-12-01 | The Royal College of Surgeons in Ireland | Ursodeoxycholsäurederivate zur Behandlung von Diarrhöe |
EP3400944B1 (de) | 2010-11-08 | 2020-07-15 | Albireo AB | Ibat-hemmer zur behandlung von lebererkrankungen |
US10709755B2 (en) | 2014-06-25 | 2020-07-14 | Elobix Ab | Solid formulation and method for preventing or reducing coloration thereof |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
CA3071285A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
CA3100113A1 (en) | 2018-06-05 | 2019-12-12 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
KR20210024033A (ko) | 2018-06-20 | 2021-03-04 | 알비레오 에이비 | 오데빅시바트의 약학 제제 |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
FI4069360T3 (fi) | 2019-12-04 | 2024-02-20 | Albireo Ab | Bentsotia(di)atsepiinin yhdisteet ja niiden käyttö sappihapon modulaattoreina |
EP4069359B1 (de) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepinverbindungen und ihre verwendung als gallensäuremodulatoren |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
ES2973355T3 (es) | 2019-12-04 | 2024-06-19 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar |
CA3158184A1 (en) | 2019-12-04 | 2021-08-10 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
JP2023537285A (ja) | 2020-08-03 | 2023-08-31 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
EP4243831A1 (de) | 2020-11-12 | 2023-09-20 | Albireo AB | Odevixibat zur behandlung von progressiver familiärer intrahepatischer cholestase (pfic) |
EP4255565A1 (de) | 2020-12-04 | 2023-10-11 | Albireo AB | Benzothia(di)azepin-verbindungen und ihre verwendung als gallensäuremodulatoren |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8825526D0 (en) * | 1988-11-01 | 1988-12-07 | Enzymatix Ltd | Diagnosis |
US5175320A (en) * | 1989-04-17 | 1992-12-29 | Giuliani S.P.A. | Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
US5843929A (en) | 1996-03-22 | 1998-12-01 | Mayo Foundation For Medical Education And Research | Chemoprevention of metachronous adenomatous colorectal polyps |
-
1997
- 1997-05-22 ES ES97925934T patent/ES2306459T3/es not_active Expired - Lifetime
- 1997-05-22 WO PCT/EP1997/002632 patent/WO1997044043A1/en active IP Right Grant
- 1997-05-22 AU AU30915/97A patent/AU3091597A/en not_active Abandoned
- 1997-05-22 EP EP97925934A patent/EP0906106B1/de not_active Expired - Lifetime
- 1997-05-22 PT PT97925934T patent/PT906106E/pt unknown
- 1997-05-22 JP JP09541562A patent/JP2000510858A/ja active Pending
- 1997-05-22 CA CA002253593A patent/CA2253593C/en not_active Expired - Fee Related
- 1997-05-22 DE DE69738667T patent/DE69738667D1/de not_active Expired - Lifetime
- 1997-05-22 AT AT97925934T patent/ATE394107T1/de not_active IP Right Cessation
-
2000
- 2000-10-06 US US09/684,585 patent/US6426340B1/en not_active Expired - Fee Related
-
2009
- 2009-11-02 JP JP2009252071A patent/JP2010059175A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2010059175A (ja) | 2010-03-18 |
ES2306459T3 (es) | 2008-11-01 |
WO1997044043A1 (en) | 1997-11-27 |
EP0906106A1 (de) | 1999-04-07 |
CA2253593C (en) | 2008-07-08 |
AU3091597A (en) | 1997-12-09 |
US6426340B1 (en) | 2002-07-30 |
PT906106E (pt) | 2008-08-07 |
JP2000510858A (ja) | 2000-08-22 |
EP0906106B1 (de) | 2008-05-07 |
ATE394107T1 (de) | 2008-05-15 |
CA2253593A1 (en) | 1997-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69738667D1 (de) | Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure | |
EP0902789A4 (de) | ||
HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
DE69320646D1 (de) | Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'-halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff | |
ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
TR199900951T2 (xx) | G���s kanserinin engellenmesi i�in y�ntemler. | |
MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
TR199701520T1 (xx) | Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu. | |
CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
MY126321A (en) | Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer. | |
CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
AU4937499A (en) | Use of succinic acid or salts thereof and method of treating insulin resistance | |
NO984196L (no) | FremgangsmÕte for behandling av stoffmisbruk | |
AU4042795A (en) | Treatment of non-small cell lung carcinoma | |
WO1995005364A3 (en) | Inhibitors of biogenic amine transporters | |
DK1019066T3 (da) | Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand | |
RU96102110A (ru) | Способ профилактики и лечения изъязвлений роговицы | |
MD1296F1 (en) | The Nicolau method of treatment of the lichen planus | |
TR200102262T2 (tr) | Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem. | |
MX9701529A (es) | Uso de (e)-1-[4'-(2-alquilaminoetoxi)fenil]-1-(3'-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos. | |
AU4918900A (en) | Interferon-beta use in the treatment of ewing's family of tumors | |
MX9701528A (es) | Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. | |
WO2002076405A3 (en) | Compositions and methods of treatment of ulcerating diseases, burns, and related conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |